LLYEli Lilly
Non-AI PillarsTarget allocation 9%
A pharmaceutical earnings stream with no correlation to whether AI turns out to be a bubble. One of four holdings meant to keep working even if the whole AI thesis is wrong.
This is a short English summary. The full thesis — buy/sell conditions, earnings notes, and the reasoning behind them — is only published in Japanese.Read the full Japanese record →